Acadia Healthcare (ACHC) Expected to Release Quarterly Earnings on Tuesday

Key Points

• Acadia Healthcare is expected to report Q2 2026 earnings after the market closes on Tuesday, July 28, with the earnings call scheduled for Wednesday, July 29 at 9:00 AM ET.
• Analysts are looking for $0.33 per share in earnings and $848.1 million in revenue, while the company’s own guidance calls for 0.300 to 0.400 EPS.
• In its last quarter, Acadia beat expectations with $0.37 EPS and $828.8 million in revenue; analyst sentiment is mixed overall, with a consensus Hold rating and an average price target of $28.69.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) is expected to announce its Q2 2026 results after the market closes on Tuesday, July 28th. Analysts expect Acadia Healthcare to announce earnings of $0.33 per share and revenue of $848.0850 million for the quarter. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Parties are encouraged to explore the company's upcoming Q2 2026 earning results page for the latest details on the call scheduled for Wednesday, July 29, 2026 at 9:00 AM ET.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The business had revenue of $828.80 million for the quarter, compared to analyst estimates of $823.51 million. During the same period in the previous year, the business earned $0.40 EPS. The firm's revenue was up 7.6% on a year-over-year basis. On average, analysts expect Acadia Healthcare to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $34.43 on Tuesday. The firm has a market capitalization of $3.17 billion, a PE ratio of -2.81, a price-to-earnings-growth ratio of 11.51 and a beta of 0.64. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.27. Acadia Healthcare has a 12-month low of $11.43 and a 12-month high of $34.90. The firm has a 50-day moving average price of $26.97 and a 200 day moving average price of $22.66.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on ACHC shares. Weiss Ratings reiterated a "sell (d)" rating on shares of Acadia Healthcare in a research note on Friday, June 12th. Royal Bank Of Canada boosted their price target on Acadia Healthcare from $28.00 to $31.00 and gave the company an "outperform" rating in a research note on Monday, May 4th. TD Cowen upped their price target on Acadia Healthcare from $30.00 to $36.00 and gave the company a "buy" rating in a research report on Tuesday, July 14th. KeyCorp lifted their price objective on Acadia Healthcare from $30.00 to $40.00 and gave the company an "overweight" rating in a report on Tuesday, July 14th. Finally, Raymond James Financial upgraded shares of Acadia Healthcare from an "outperform" rating to a "strong-buy" rating and set a $39.00 target price on the stock in a research note on Monday, May 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $28.69.

Institutional Trading of Acadia Healthcare

Several large investors have recently made changes to their positions in ACHC. Wells Fargo & Company MN lifted its position in Acadia Healthcare by 208.9% during the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company's stock worth $32,000 after buying an additional 1,510 shares in the last quarter. EverSource Wealth Advisors LLC increased its position in Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company's stock valued at $32,000 after acquiring an additional 497 shares in the last quarter. Aristides Capital LLC bought a new position in shares of Acadia Healthcare in the fourth quarter worth about $196,000. Prudential Financial Inc. lifted its position in shares of Acadia Healthcare by 21.9% during the second quarter. Prudential Financial Inc. now owns 9,903 shares of the company's stock worth $225,000 after purchasing an additional 1,780 shares in the last quarter. Finally, Glenmede Investment Management LP lifted its position in shares of Acadia Healthcare by 15.6% during the third quarter. Glenmede Investment Management LP now owns 11,379 shares of the company's stock worth $282,000 after purchasing an additional 1,532 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.